Cumberland Pharmaceuticals Inc (CPIX)
1.20
+0.06
(+5.26%)
USD |
NASDAQ |
Nov 05, 16:00
1.20
0.00 (0.00%)
After-Hours: 16:23
Cumberland Pharmaceuticals Shareholders Equity (Quarterly): 26.35M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 26.35M |
March 31, 2024 | 27.49M |
December 31, 2023 | 29.60M |
September 30, 2023 | 35.99M |
June 30, 2023 | 37.16M |
March 31, 2023 | 36.36M |
December 31, 2022 | 36.27M |
September 30, 2022 | 38.76M |
June 30, 2022 | 39.46M |
March 31, 2022 | 41.02M |
December 31, 2021 | 42.81M |
September 30, 2021 | 46.82M |
June 30, 2021 | 47.95M |
March 31, 2021 | 47.02M |
December 31, 2020 | 46.99M |
September 30, 2020 | 47.93M |
June 30, 2020 | 48.48M |
March 31, 2020 | 49.89M |
December 31, 2019 | 51.12M |
September 30, 2019 | 51.73M |
June 30, 2019 | 54.06M |
March 31, 2019 | 55.43M |
December 31, 2018 | 55.84M |
September 30, 2018 | 58.20M |
June 30, 2018 | 59.91M |
Date | Value |
---|---|
March 31, 2018 | 61.09M |
December 31, 2017 | 64.12M |
September 30, 2017 | 65.10M |
June 30, 2017 | 66.66M |
March 31, 2017 | 72.36M |
December 31, 2016 | 73.25M |
September 30, 2016 | 74.53M |
June 30, 2016 | 74.47M |
March 31, 2016 | 75.40M |
December 31, 2015 | 76.89M |
September 30, 2015 | 77.59M |
June 30, 2015 | 78.74M |
March 31, 2015 | 79.37M |
December 31, 2014 | 80.76M |
September 30, 2014 | 81.10M |
June 30, 2014 | 80.93M |
March 31, 2014 | 79.15M |
December 31, 2013 | 79.47M |
September 30, 2013 | 81.10M |
June 30, 2013 | 83.03M |
March 31, 2013 | 85.17M |
December 31, 2012 | 85.70M |
September 30, 2012 | 83.45M |
June 30, 2012 | 83.32M |
March 31, 2012 | 81.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
26.35M
Minimum
Jun 2024
51.12M
Maximum
Dec 2019
40.92M
Average
41.02M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 78.52M |
Total Liabilities (Quarterly) | 52.49M |
Debt to Equity Ratio | 0.6107 |
Current Ratio | 1.437 |
Net Debt Paydown Yield | -0.02% |